Atlas Trials

Respiratory Syncytial Virus (RSV)

71 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Respiratory Syncytial Virus (RSV)

RecordFirmDate
Antibiotic Therapy in Viral Airway Infections (NCT05045612)University Hospital, Akershus2022-01-13
Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months (NCT04909021)Meissa Vaccines, Inc.2021-06-03
Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects (NCT04927793)Enanta Pharmaceuticals, Inc2021-05-28
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® (NCT04896853)NextCell Pharma Ab2021-05-18
Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, Pakistan (NCT05047549)Aga Khan University2020-11-02
Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa (NCT05277298)National Institute for Communicable Diseases, South Africa2020-07-01
Effects of Prone Positioning on Vital Parameters in Infants With Acute Bronchiolitis (NCT04748159)Luzerner Kantonsspital2020-01-03
A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. (NCT04225897)Pfizer2019-11-13
Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age (NCT03916185)National Institute of Allergy and Infectious Diseases (NIAID)2019-06-20
High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue (NCT03095495)Hamad Medical Corporation2018-08-14
Understanding RSV: Severe Disease and the Long Term Consequences (NCT03756766)University of Oxford2017-12-19
Respiratory Syncytial Virus (RSV) and Vaccination in Pregnancy (NCT03096574)University Hospital Southampton NHS Foundation Trust2017-06-01
Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f) (NCT02830932)Vaxart2016-06-22
Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection (NCT02534350)Gilead Sciences2015-12-31
A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults (NCT02608502)Novavax2015-11-01
A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults (NCT02289820)MedImmune LLC2015-01-05
A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults (NCT02298179)GlaxoSmithKline2014-12-19
Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis (NCT02282982)AbbVie2014-10-01
A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults (NCT02115815)MedImmune LLC2014-04-01
Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer (NCT02067286)IQuum, Inc.2014-01-01
Infection With Respiratory Syncytial Virus in Infants (NCT04925310)Hannover Medical School2013-10-01
RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly (NCT01709019)Novavax2012-10-01
RSV-F Vaccine Dose Ranging Study in Young Women (NCT01704365)Novavax2012-10-01
Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden (NCT05622331)Sanofi Pasteur, a Sanofi Company2006-07-01

Track Respiratory Syncytial Virus (RSV) automatically

Every clearance here is in the API, with alerts when new ones post.